Cost-Effectiveness of Erythrocytapheresis in Children and Young Adults with Beta Thalassemia Major and Sickle Cell Disease

被引：0
|
作者：
Van Hattem, Jessica [1 ,2 ]
Maes, Philip [2 ,3 ]
Esterhuizen, Tonya [4 ,5 ]
De Vos, Ann [2 ,3 ]
Ruppert, Martin [2 ,6 ]
van Heerden, Jaques [2 ,3 ]
机构：
[1] Antwerp Univ Hosp, Dept Pediat & Child Hlth, Antwerp, Belgium
[2] Antwerp Univ Hosp, Edegem, Belgium
[3] Antwerp Univ Hosp, Dept Pediat Haematol & Oncol, Antwerp, Belgium
[4] Stellenbosch Univ, Fac Med & Hlth Sci, Div Epidemiol & Biostat, Stellenbosch, South Africa
[5] Stellenbosch Univ, Stellenbosch, South Africa
[6] Antwerp Univ Hosp, Dept Abdominal Pediat & Reconstruct Surg, Antwerp, Belgium
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-186590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] The clinical effectiveness and cost-effectiveness of primary stroke prevention in children with sickle cell disease: a systematic review and economic evaluation
    Cherry, M. G.
    Greenhalgh, J.
    Osipenko, L.
    Venkatachalam, M.
    Boland, A.
    Dundar, Y.
    Marsh, K.
    Dickson, R.
    Rees, D. C.
    HEALTH TECHNOLOGY ASSESSMENT, 2012, 16 (43) : 1 - +
  • [22] SICKLE-CELL-ANEMIA, SICKLE-CELL BETA-THALASSEMIA, AND THALASSEMIA MAJOR IN ALBANIA - CHARACTERIZATION OF MUTATIONS
    BOLETINI, E
    SVOBODOVA, M
    DIVOKY, V
    BAYSAL, E
    CURUK, MA
    DIMOVSKI, AJ
    LIANG, R
    ADEKILE, AD
    HUISMAN, THJ
    HUMAN GENETICS, 1994, 93 (02) : 182 - 187
  • [23] Hypercoagulability in Sickle Cell Disease and Beta-Thalassemia
    Singer, Sylvia T.
    Ataga, Kenneth I.
    CURRENT MOLECULAR MEDICINE, 2008, 8 (07) : 639 - 645
  • [24] HYPERCOAGULABILITY IN BETA-THALASSEMIA AND SICKLE CELL DISEASE
    Thisiadou, K.
    Chalvatzi, K.
    Arampatzi, S.
    Spiroglou, S.
    Kanonidou, C.
    Lazaridou, D.
    Nikolaidou, A.
    Fotakeli, O.
    Diza, E.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 757 - 758
  • [25] The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature
    Jiao, Boshen
    Basu, Anirban
    Roth, Joshua
    Bender, M.
    Rovira, Ilsa
    Clemons, Traci
    Quach, Dalyna
    Ramsey, Scott
    Devine, Beth
    PHARMACOECONOMICS, 2021, 39 (11) : 1225 - 1241
  • [26] Cost-effectiveness of newborn screening for sickle cell disease: a systematic review protocol
    Mahapatra, Biswajit
    Mukherjee, Nirmalya
    Khatoon, Sajda
    Bhattacharya, Paramita
    Thubru, Edakashwa
    John, Denny
    JBI EVIDENCE SYNTHESIS, 2024, 22 (06) : 1143 - 1150
  • [27] Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain
    Castilla-Rodriguez, Ivan
    Cela, Elena
    Vallejo-Torres, Laura
    Valcarcel-Nazco, Cristina
    Dulin, Elena
    Espada, Mercedes
    Rausell, Dolores
    Mar, Javier
    Serrano-Aguilar, Pedro
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (06): : 567 - 575
  • [28] The Use of Cost-Effectiveness Analysis in Sickle Cell Disease: A Critical Review of the Literature
    Boshen Jiao
    Anirban Basu
    Joshua Roth
    M. Bender
    Ilsa Rovira
    Traci Clemons
    Dalyna Quach
    Scott Ramsey
    Beth Devine
    PharmacoEconomics, 2021, 39 : 1225 - 1241
  • [29] Bone mineral density in children and young adults with beta-thalassemia major conventionally treated
    Christoforidis, A
    Hatzipantelis, E
    Tsatra, I
    Katzos, G
    Athanassiou-Metaxa, M
    PEDIATRIC BLOOD & CANCER, 2006, 47 (01) : 113 - 114
  • [30] Commentary: Heterogeneity of respiratory disease in children and young adults with sickle cell disease
    Cohen, Robyn T.
    Klings, Elizabeth S.
    THORAX, 2018, 73 (06) : 503 - 503
12345